| 2002 | | Activation of extracellular signal regulated kinase 1/2 in human dermal microvascular endothelial cells stimulated by anti-endothelial cell antibodies in sera of patients with Behçet's disease. | 이성낙 |
| 2021 | | Adamantiades-Behçet's disease (Behçet's disease) and COVID-19 | 이은소 |
| 2024 | | All-cause and cause-specific mortality in patients with Behçet disease versus the general population | 이은소 |
| 2011 | | Altered expression of costimulatory molecules in Behçet's disease according to clinical activity. | 박선, 이은소 |
| 2011 | | Anti-alpha-enolase antibody as a serologic marker and its correlation with disease severity in intestinal Behçet's disease | 신성재 |
| 2007 | | Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease. | 손성향, 이은소 |
| 2005 | | Association of HYPA haplotype in the mannose-binding lectin gene-2 with Behçet's disease. | 이은소 |
| 2005 | | Behçet's disease combined with various types of fistula. | 이은소 |
| 1998 | | Behçet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. | 손성향, 이성낙, 이은소 |
| 2003 | | Behçet's disease: the first Mongolian case in literature showing HLA B51, MICA gene type *5/*6. | 이성낙, 이은소 |
| 2013 | | CCL21 attenuates HSV-induced inflammation through up-regulation of CD8+ memory cells. | 손성향, 이은소 |
| 2014 | | CD11a, CD11c, and CD18 gene polymorphisms and susceptibility to Behçet's disease in Koreans. | 이은소 |
| 2016 | | CD11c is upregulated in CD8+ T cells of patients with Behcet's disease | 박선, 박영준, 이은소 |
| 2011 | | CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model. | 박선, 손성향, 이은소 |
| 2015 | | Changes in Ocular Manifestations of Behçet Disease in Korean Patients over Time: A Single-center Experience in the 1990s and 2000s. | 송지훈, 이은소 |
| 2023 | | Characterization of immune responses associated with ERAP-1 expression in HSV-induced Behçet's disease mouse model | 손성향 |
| 2018 | | Choroidal Thickness Indicates Subclinical Ocular and Systemic Inflammation in Eyes with Behcet Disease without Active Inflammation | 이기황, 이은소, 정유리 |
| 2015 | | Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease. | 송지훈, 이기황, 이은소, 정유리 |
| 2003 | | Clinical features of Behçet's disease patients with epididymitis. | 이성낙, 이은소 |
| 2003 | | Clinical features of patients with Behçet's disease and epididymitis. | 이성낙, 이은소 |
| 2005 | | Coexistence of Behçet's disease and autoimmune disease: clinical features of 11 cases. | 이은소 |
| 2003 | | Combined treatment with colchicine and Herba Taraxaci (Tarazacum mongolicum Hand.-Mazz.) attenuates Behcet's disease-like symptoms in mice and influences the expressions of cytokines. | 손성향, 이성낙, 이은소 |
| 2014 | | Could increased IgA induced by BAFF be the cause of IgA nephropathy development in Behcet’s disease? Comment on: Behcet’s disease and IgA nephropathy (Rheumatol Int. 2012 Jul; 32(7):2227–9) | 박세진 |
| 2013 | | Detection of the inflammatory process in a Behçet's disease-like mouse model using 18F-fluorodeoxyglucose positron emission tomography. | 손성향 |
| 2003 | | Development of clinical activity form for Korean patients with Behçet's disease. | 이성낙, 이은소 |
| 2019 | | Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behcet's Disease with Arthritis | 김현아, 서창희, 손성향, 정주양 |
| 2012 | | Differential effects of colchicine in blood mononuclear cells of patients with Behçet disease in relation to colchicine responsiveness | 김경민, 박선, 이미진, 이은소 |
| 2020 | | Differential expression of novel genes and signalling pathways of senescent CD8+ T cell subsets in Behcet's disease | 김소민, 박선, 이은소, 정재연 |
| 2012 | | Differential expression of T cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) according to activity of Behçet's disease | 박선, 이은소 |
| 2023 | | Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea | 신성재 |
| 2023 | | Efficacy and Safety of Infliximab in Intestinal Behçet's Disease: A Multicenter, Phase 3 Study (BEGIN) | 신성재 |
| 2021 | | Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83 | 김현아, 서창희, 손성향, 유혜명, 정주양 |
| 2001 | | Experimental studies on the antiviral agent famciclovir in Behçet's disease symptoms in ICR mice. | 손성향, 이성낙, 이은소 |
| 2001 | | Expression of Th2 cytokines decreases the development of and improves Behçet's disease-like symptoms induced by herpes simplex virus in mice. | 손성향, 이성낙, 이은소 |
| 2014 | | Frequency of immunoglobulin G4-related aortitis in cases with aortic resection and their clinical characteristics compared to other aortitises. | 고영화 |
| 2012 | | Galectin-9 ameliorates herpes simplex virus-induced inflammation through apoptosis. | 박선, 손성향, 이은소 |
| 2007 | | HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease. | 손성향, 이은소 |
| 2018 | | HSV-Induced Systemic Inflammation as an Animal Model for Behcet's Disease and Therapeutic Applications | 손성향 |
| 2015 | | IL-2/IL-2 antibody immune complex regulates HSV-induced inflammation through induction of IL-2 receptor alpha, beta, and gamma in a mouse model. | 손성향, 이은소 |
| 2006 | | Increased risk of human leukocyte antigen-G gene variants in Behçet's disease. | 이은소 |
| 2018 | | Increased senescent CD8+ T cells in the peripheral blood mononuclear cells of Behcet's disease patients | 박선, 이은소 |
| 2003 | | Influence of sex on patients with Behçet's disease in Korea. | 이성낙, 이은소 |
| 2019 | | Inhibition of CD83 Alleviates Systemic Inflammation in Herpes Simplex Virus Type 1-Induced Behcet's Disease Model Mouse | 손성향 |
| 2023 | | Integrative metabolomics of plasma and PBMCs identifies distinctive metabolic signatures in Behçet’s disease | 박선, 이은소 |
| 2003 | | Intercellular adhesion molecule-1 polymorphisms in Korean patients with Behcet s disease. | 이성낙, 이은소 |
| 2021 | | Interrelationship of Stress, Environment, and Herpes Simplex Virus Type-1 on Behçet’s Disease: Using a Mouse Model | 손성향, 유혜명 |
| 2012 | | Learning from HSV-infected mice as a model of Behçet's disease | 손성향, 이은소 |
| 2012 | | Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease | 이은소 |
| 2016 | | MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Behcet's disease | 박선, 이은소 |
| 2013 | | Morbidity of solid cancer in Behςet's disease: analysis of 11 cases in a series of 506 patients. | 이은소 |
| 2017 | | Role of N-acetyl galactosamine-4-SO4, a ligand of CD206 in HSV-induced mouse model of Behcet's disease | 손성향 |
